New diabetes clinical trial: A Multi-center Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

Published on: July 12, 2019 at 07:00PM
Conditions:   Insulin Resistance - Type A;   Insulin Resistance - Type B;   Lipoatrophic Diabetes Mellitus;   Insulin Resistance Syndrome
Intervention:   Drug: Empagliflozin Tablets
Sponsors:   Kobe University;   Boehringer Ingelheim
Not yet recruiting